Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Feb;99(2):350–354. doi: 10.1111/j.1476-5381.1990.tb14707.x

Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo.

B E Banks 1, C E Dempsey 1, C A Vernon 1, J A Warner 1, J Yamey 1
PMCID: PMC1917405  PMID: 2328399

Abstract

1. The relationship between the anti-inflammatory activity of the bee venom peptide 401 in the carrageenin-induced oedema of the rat hind paw and its mast cell degranulating activity has been reinvestigated. 2. Mast cell degranulation caused by compound 48/80 (10 mg kg-1) or by allergen challenge in rats sensitized to Nippostrongylus brasiliensis also suppressed rat hind paw oedema in the same test. 3. The anti-inflammatory activities of peptide 401 and compound 48/80 were partially suppressed by pretreatment of rats with mepyramine and methysergide, at doses (2.5 mg kg-1) that completely suppressed skin reactions to these mast cell-derived amines. Pretreatment of rats with compound 48/80 also suppressed the apparent anti-inflammatory actions of peptide 401 and of compound 48/80. 4. Injection of peptide 401 together with carrageenin increased the inflammatory response in the rat hind paw. 5. The anti-inflammatory activity of peptide 401 and of compound 48/80 in the carrageenin-induced swelling of the rat hind paw arises from mast cell degranulation in vivo.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atherton A., Born G. V. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls. J Physiol. 1972 Apr;222(2):447–474. doi: 10.1113/jphysiol.1972.sp009808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkins P. C., Norman M. E., Zweiman B. Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate. J Allergy Clin Immunol. 1978 Sep;62(3):149–155. doi: 10.1016/0091-6749(78)90099-4. [DOI] [PubMed] [Google Scholar]
  3. Atkinson D. C., Hicks R. The anti-inflammatory activity of irritants. Agents Actions. 1975 Aug;5(3):239–249. doi: 10.1007/BF02026438. [DOI] [PubMed] [Google Scholar]
  4. Banks B. E., Dempsey C. E., Pearce F. L., Vernon C. A., Wholley T. E. New methods of isolating been venom peptides. Anal Biochem. 1981 Sep 1;116(1):48–52. doi: 10.1016/0003-2697(81)90320-1. [DOI] [PubMed] [Google Scholar]
  5. Billingham M. E., Morley J., Hanson J. M., Shipolini R. A., Vernon C. A. Letter: An anti-inflammatory peptide from bee venom. Nature. 1973 Sep 21;245(5421):163–164. doi: 10.1038/245163a0. [DOI] [PubMed] [Google Scholar]
  6. Breithaupt H., Habermann E. Mastzelldegranulierendes Peptid (MCD-Pepid) aus Bienengift: Isolierung, biochemische und pharmakologische Eigenschaften. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;261(3):252–270. [PubMed] [Google Scholar]
  7. Dempsey C. E., Banks B. E., Roberts N. A., Vernon C. A. Inhibition of prostaglandin biosynthesis by the mast-cell-degranulating agent compound 48/80 but not by the mast-cell-degranulating peptide (peptide-401) from bee venom. Biochem Pharmacol. 1985 Jul 1;34(13):2391–2394. doi: 10.1016/0006-2952(85)90801-9. [DOI] [PubMed] [Google Scholar]
  8. Di Rosa M., Giroud J. P., Willoughby D. A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971 May;104(1):15–29. doi: 10.1002/path.1711040103. [DOI] [PubMed] [Google Scholar]
  9. Gauldie J., Hanson J. M., Rumjanek F. D., Shipolini R. A., Vernon C. A. The peptide components of bee venom. Eur J Biochem. 1976 Jan 15;61(2):369–376. doi: 10.1111/j.1432-1033.1976.tb10030.x. [DOI] [PubMed] [Google Scholar]
  10. Hanson J. M., Morley J., Soria-Herrera C. Anti-inflammatory property of 401 (MCD-peptide), a peptide from the venom of the bee Apis mellifera (L.). Br J Pharmacol. 1974 Mar;50(3):383–392. doi: 10.1111/j.1476-5381.1974.tb09613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lichtenstein L. M., Gillespie E. The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine. J Pharmacol Exp Ther. 1975 Feb;192(2):441–450. [PubMed] [Google Scholar]
  12. Soter N. A. High molecular weight neutrophil chemotactic factor: recognition, characterization, and role in the deactivation of neutrophillic leukocytes. J Invest Dermatol. 1980 May;74(5):354–356. doi: 10.1111/1523-1747.ep12543639. [DOI] [PubMed] [Google Scholar]
  13. Tannenbaum S., Oertel H., Henderson W., Kaliner M. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J Immunol. 1980 Jul;125(1):325–335. [PubMed] [Google Scholar]
  14. Vinegar R., Truax J. F., Selph J. L. Quantitative studies of the pathway to acute carrageenan inflammation. Fed Proc. 1976 Nov;35(13):2447–2456. [PubMed] [Google Scholar]
  15. Vinegar R., Truax J. F., Selph J. L., Voelker F. A. Pathway of onset, development, and decay of carrageenan pleurisy in the rat. Fed Proc. 1982 Jul;41(9):2588–2595. [PubMed] [Google Scholar]
  16. White J. R., Pearce F. L. Characteristics of histamine secretion from rat peritoneal mast cells sensitized to the nematode Nippostrongylus brasiliensis. Immunology. 1982 Jun;46(2):353–359. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES